Literature DB >> 17869579

Nosocomial infection: a risk factor for a complicated course in children with respiratory syncytial virus infection--results from a prospective multicenter German surveillance study.

Arne Simon1, Andreas Müller, Karun Khurana, Steffen Engelhart, Martin Exner, Oliver Schildgen, Anna M Eis-Hübinger, Wolfgang Kamin, Thomas Schaible, Karoline Wadas, Roland A Ammann, Anja Wilkesmann.   

Abstract

BACKGROUND: Nosocomially acquired respiratory syncytial virus infections (RSV-NI) may cause serious problems in hospitalized paediatric patients. Hitherto, prospectively collected representative data on RSV-NI from multicenter studies in Germany are limited.
METHODS: The DMS RSV Ped database was designed for the prospective multicenter documentation and analysis of clinically relevant aspects of the management of inpatients with RSV-infection. The study covered six consecutive seasons (1999-2005); the surveillance took place in 14 paediatric hospitals in Germany.
RESULTS: Of the 1568 prospectively documented RSV-infections, 6% (n=90) were NI and 94% (n=1478) were community acquired (CA). A significantly higher proportion in the NI group displayed additional risk factors like prematurity, chronic lung disease, mechanical ventilation (med. history), congenital heart disease, and neuromuscular impairment. Of all NI, 55% occurred in preterms (30.6% of all RSV-infections in preterms with severe chronic lung disease of prematurity were NI). Illness severity as well as the total mortality, but not the attributable mortality was significantly higher in the NI group. In the multivariate analysis, NI was significantly associated with the combined outcome 'complicated course of disease'.
CONCLUSION: This is the first prospective multicenter study from Germany, which confirms the increased risk of a severe clinical course in nosocomially acquired RSV-infection. Of great concern is the high rate of (preventable) NI in preterms, in particular in those with severe chronic lung disease or with mechanical ventilation due to other reasons.

Entities:  

Mesh:

Year:  2007        PMID: 17869579     DOI: 10.1016/j.ijheh.2007.07.020

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  19 in total

1.  A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice.

Authors:  Bosco A Paes; Ian Mitchell; Anna Banerji; Krista L Lanctôt; Joanne M Langley
Journal:  Can Respir J       Date:  2011 Mar-Apr       Impact factor: 2.409

2.  Impact of the viral respiratory season on postoperative outcomes in children undergoing cardiac surgery.

Authors:  Michael C Spaeder; Kathryn A Carson; Luca A Vricella; Diane E Alejo; Kathryn W Holmes
Journal:  Pediatr Cardiol       Date:  2011-04-11       Impact factor: 1.655

3.  A model of the costs of community and nosocomial pediatric respiratory syncytial virus infections in Canadian hospitals.

Authors:  Philip Jacobs; Douglas Lier; Katherine Gooch; Katharina Buesch; Michelle Lorimer; Ian Mitchell
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

4.  Predictors of severity and mortality in children hospitalized with respiratory syncytial virus infection in a tropical region.

Authors:  Diego Andrés Rodríguez; Carlos E Rodríguez-Martínez; Andrea Constanza Cárdenas; Ivonne Emilce Quilaguy; Leydy Yasmin Mayorga; Luz Marlesvy Falla; Gustavo Nino
Journal:  Pediatr Pulmonol       Date:  2013-02-08

Review 5.  Best practice in the prevention and management of paediatric respiratory syncytial virus infection.

Authors:  Simon B Drysdale; Christopher A Green; Charles J Sande
Journal:  Ther Adv Infect Dis       Date:  2016-02-10

6.  Respiratory syncytial virus infection in children with neuromuscular impairment.

Authors:  Arne Simon; Julia Prusseit; Andreas Müller
Journal:  Open Microbiol J       Date:  2011-12-30

Review 7.  Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus.

Authors:  Swapnil Subhash Bawage; Pooja Munnilal Tiwari; Shreekumar Pillai; Vida Dennis; Shree Ram Singh
Journal:  Adv Virol       Date:  2013-12-09

8.  Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants.

Authors:  Eugenio Baraldi; Marcello Lanari; Paolo Manzoni; Giovanni A Rossi; Silvia Vandini; Alessandro Rimini; Costantino Romagnoli; Pierluigi Colonna; Andrea Biondi; Paolo Biban; Giampietro Chiamenti; Roberto Bernardini; Marina Picca; Marco Cappa; Giuseppe Magazzù; Carlo Catassi; Antonio Francesco Urbino; Luigi Memo; Gianpaolo Donzelli; Carlo Minetti; Francesco Paravati; Giuseppe Di Mauro; Filippo Festini; Susanna Esposito; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2014-10-24       Impact factor: 2.638

9.  Bronchoscopic interventions with surfactant and recombinant human deoxyribonuclease for acute respiratory distress syndrome-type respiratory syncytial virus-pneumonia in moderately preterm infants: Case series.

Authors:  Martin F Krause; Tobias Ankermann
Journal:  SAGE Open Med Case Rep       Date:  2014-10-08

10.  Respiratory syncytial virus-associated hospitalizations over three consecutive seasons in children with congenital heart disease.

Authors:  B Resch; S Kurath-Koller; J Hahn; W Raith; M Köstenberger; A Gamillscheg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-28       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.